Funding Rounds
Calluna Pharma

Calluna Pharma Series A (2024, $81M)

Calluna Pharma

Developer of therapies for inflammatory and fibrotic diseases.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $81.72M

Investors